Form 8-K - Current report:
SEC Accession No. 0001104659-25-084879
Filing Date
2025-08-28
Accepted
2025-08-28 17:30:07
Documents
15
Period of Report
2025-08-28
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2524202d2_8kseq1.htm   iXBRL 8-K 33032
2 EXHIBIT 5.1 tm2524202d2_ex5-1.htm EX-5.1 12400
3 EXHIBIT 10.1 tm2524202d2_ex10-1.htm EX-10.1 294082
7 GRAPHIC tm2524202d2_ex5-1img001.jpg GRAPHIC 5057
  Complete submission text file 0001104659-25-084879.txt   582708

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA derm-20250828.xsd EX-101.SCH 3044
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE derm-20250828_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE derm-20250828_pre.xml EX-101.PRE 22378
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2524202d2_8kseq1_htm.xml XML 3784
Mailing Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258
Business Address 9237 E VIA DE VENTURA BLVD., SUITE 105 SCOTTSDALE AZ 85258 480-434-6670
Journey Medical Corp (Filer) CIK: 0001867066 (see all company filings)

EIN.: 471879539 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41063 | Film No.: 251274896
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)